Dr. Carvajal Discusses the Biology of Extracutaneous Melanoma

In Partnership With:

Partner | Cancer Centers | <b>Columbia University Herbert Irving Comprehensive Cancer Center</b>

Richard Carvajal, MD, director of Experimental Therapeutics and director of the Melanoma Service at Columbia University Medical Center, discusses the biology and distinctions of extracutaneous melanoma.

Richard Carvajal, MD, director of Experimental Therapeutics and director of the Melanoma Service at Columbia University Medical Center, discusses the biology and distinctions of extracutaneous melanoma.

Extracutaneous melanoma is a very distinct disease from a biological and clinical standpoint, according to Carvajal. Extracutaneous melanoma needs to be thought of as a different disease than cutaneous melanoma, Carvajal adds, since they do not respond to treatments the same way.